Answers are grounded in this paper and cite their sources.
The critical phase of perimenopausal period is marked by a reduction in estrogen levels, leading to various clinical issues (vasomotor and neurodegenerative symptoms, increased osteoporosis risk and cardiovascular risk). These complex clinical scenarios pose challenges to clinicians in providing the right support for diagnosis and treatment. A group of Italian cardiologists, endocrinologists, and gynecologists conducted a survey among expert colleagues to assess consensus on controversial issues and best practices for screening and treating peri- and postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Colacurci et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: